Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
March 3, 201410m 30s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Advanced Melanoma Receiving Nivolumab," by Suzanne Topalian, et al.